{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:49:01Z","timestamp":1790682541319,"version":"4.1.0"},"reference-count":145,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Fibroblasts are the chief effector cells in fibrotic diseases and have been discovered to be highly heterogeneous. Recently, fibroblast heterogeneity in human skin has been studied extensively and several surface markers for dermal fibroblast subtypes have been identified, holding promise for future antifibrotic therapies. However, it has yet to be confirmed whether surface markers should be looked upon as merely lineage landmarks or as functional entities of fibroblast subtypes, which may further complicate the interpretation of cellular function of these fibroblast subtypes. This review aims to provide an update on current evidence on fibroblast surface markers in fibrotic disorders of skin as well as of other organ systems. Specifically, studies where surface markers were treated as lineage markers and manipulated as functional membrane proteins are both evaluated in parallel, hoping to reveal the underlying mechanism behind the pathogenesis of tissue fibrosis contributed by various fibroblast subtypes from multiple angles, shedding lights on future translational researches.<\/jats:p>","DOI":"10.3389\/fphys.2021.694605","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T12:33:17Z","timestamp":1626352397000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity?"],"prefix":"10.3389","volume":"12","author":[{"given":"Xin","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Khoong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.humpath.2005.11.020","article-title":"Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis.","volume":"37","author":"Acharya","year":"2006","journal-title":"Hum. Pathol."},{"key":"B2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells.","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1096\/fj.07-105627","article-title":"Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis.","volume":"22","author":"Akhmetshina","year":"2008","journal-title":"FASEB J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/art.24186","article-title":"Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis.","volume":"60","author":"Akhmetshina","year":"2009","journal-title":"Arthrit. Rheumat."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.2337\/db14-0804","article-title":"Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function.","volume":"64","author":"Aroor","year":"2015","journal-title":"Diabetes"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.11.028","article-title":"Human dermal fibroblast subpopulations are conserved across single-Cell RNA sequencing studies.","author":"Ascensi\u00f3n","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.matbio.2017.12.003","article-title":"Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts.","volume":"67","author":"Avery","year":"2018","journal-title":"Matrix Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5551\/jat.33225","article-title":"Heart failure as a comorbidity of diabetes: role of dipeptidyl peptidase 4.","volume":"23","author":"Bando","year":"2016","journal-title":"J. Atheroscl. Thromb."},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7629724","article-title":"Clinical advancements in the targeted therapies against liver fibrosis.","volume":"2016","author":"Bansal","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"B10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/cvr\/cvs225","article-title":"EP 80317, a selective CD36 ligand, shows cardioprotective effects against post-ischaemic myocardial damage in mice.","volume":"96","author":"Bessi","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"B11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4049\/jimmunol.1401028","article-title":"Synthetic amphipathic helical peptides targeting CD36 attenuate lipopolysaccharide-induced inflammation and acute lung injury.","volume":"197","author":"Bocharov","year":"2016","journal-title":"J. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bbrc.2004.03.064","article-title":"Inhibitory effect of soluble PDGF-beta receptor in culture-activated hepatic stellate cells.","volume":"317","author":"Borkham-Kamphorst","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/jid.2011.344","article-title":"Purinergic signaling in healthy and diseased skin.","volume":"132","author":"Burnstock","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.2741\/4682","article-title":"Targeting fibroblast activation protein in cancer - prospects and caveats.","volume":"23","author":"Busek","year":"2018","journal-title":"Front. Biosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"42923","DOI":"10.18632\/oncotarget.5976","article-title":"Therapeutics targeting CD90-integrin-AMPK-CD133 signal axis in liver cancer.","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"B16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis.","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"B17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jhep.2006.04.010","article-title":"Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice.","volume":"45","author":"Czochra","year":"2006","journal-title":"J. Hepatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00403-010-1084-x","article-title":"Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option.","volume":"302","author":"Dienus","year":"2010","journal-title":"Arch. Dermatol. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/art.22314","article-title":"Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.","volume":"56","author":"Distler","year":"2007","journal-title":"Arthrit. Rheumat."},{"key":"B20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nature12783","article-title":"Distinct fibroblast lineages determine dermal architecture in skin development and repair.","volume":"504","author":"Driskell","year":"2013","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tcb.2014.10.001","article-title":"Understanding fibroblast heterogeneity in the skin.","volume":"25","author":"Driskell","year":"2015","journal-title":"Trends Cell Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nm.2848","article-title":"Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury.","volume":"18","author":"Dulauroy","year":"2012","journal-title":"Nat. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2017.05.022","article-title":"Effects of the fibroblast activation protein inhibitor, PT100, in a murine model of pulmonary fibrosis.","volume":"809","author":"Egger","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mam.2017.01.002","article-title":"and adenosine: the Yin and Yang in immune responses?","volume":"55","author":"Faas","year":"2017","journal-title":"Mol. Aspects Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.celrep.2016.01.002","article-title":"Expression of CD39 on activated T cells impairs their survival in older individuals.","volume":"14","author":"Fang","year":"2016","journal-title":"Cell Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1172\/jci14006","article-title":"CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.","volume":"108","author":"Febbraio","year":"2001","journal-title":"J. Clin. Invest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.ajpath.2013.08.024","article-title":"Extracellular generation of adenosine by the ectonucleotidases CD39 and CD73 promotes dermal fibrosis.","volume":"183","author":"Fern\u00e1ndez","year":"2013","journal-title":"Am. J. Pathol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1096\/fj.15-274563","article-title":"Purinergic signaling in scarring.","volume":"30","author":"Ferrari","year":"2016","journal-title":"FASEB J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1083\/jcb.201505007","article-title":"Conformational coupling of integrin and Thy-1 regulates Fyn priming and fibroblast mechanotransduction.","volume":"211","author":"Fiore","year":"2015","journal-title":"J. Cell Biol."},{"key":"B30","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.18553\/jmcp.2017.23.3-b.s5","article-title":"Systematic review and network meta-analysis of idiopathic pulmonary fibrosis treatments.","author":"Fleetwood","year":"2017","journal-title":"J. Manag. Care Special. Pharm."},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1186\/ar4606","article-title":"Low-dose oral imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide: a phase II pilot study.","volume":"16","author":"Fraticelli","year":"2014","journal-title":"Arthrit. Res. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/nep.12618","article-title":"Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.","volume":"21","author":"Gangadharan Komala","year":"2016","journal-title":"Nephrology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature12614","article-title":"Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma.","volume":"503","author":"Gerber","year":"2013","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.2869","article-title":"Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry.","volume":"11","author":"Giesen","year":"2014","journal-title":"Nat. Methods"},{"key":"B35","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.bbrc.2006.05.175","article-title":"Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPalpha).","volume":"346","author":"Gilmore","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B36","first-page":"189","article-title":"Imatinib mesylate (GleevecTM) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trial.","author":"Gordon","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"B37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-08247-x","article-title":"Single-cell analysis reveals fibroblast heterogeneity and myeloid-derived adipocyte progenitors in murine skin wounds.","volume":"10","author":"Guerrero-Juarez","year":"2019","journal-title":"Nat. Commun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/prs.0000000000003542","article-title":"Thy1 (CD90) expression is elevated in radiation-induced periprosthetic capsular contracture: implication for novel therapeutics.","volume":"140","author":"Hansen","year":"2017","journal-title":"Plast. Reconstruct. Surg."},{"key":"B39","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1124\/jpet.112.194357","article-title":"Vaccination with platelet-derived growth factor B kinoids inhibits CCl4-induced hepatic fibrosis in mice.","volume":"342","author":"Hao","year":"2012","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1038\/s41556-019-0417-z","article-title":"A Tppp3(+)Pdgfra(+) tendon stem cell population contributes to regeneration and reveals a shared role for PDGF signalling in regeneration and fibrosis.","volume":"21","author":"Harvey","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092925","article-title":"Activation of platelet-derived growth factor receptor alpha contributes to liver fibrosis.","volume":"9","author":"Hayes","year":"2014","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"crossref","first-page":"L682","DOI":"10.1152\/ajplung.00439.2017","article-title":"Cell-surface phenotyping identifies CD36 and CD97 as novel markers of fibroblast quiescence in lung fibrosis.","volume":"315","author":"Heinzelmann","year":"2018","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis.","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/dad.0000000000001254","article-title":"Extensive CD34-to-CD90 fibroblast transition defines regions of cutaneous reparative, hypertrophic, and keloidal scarring.","volume":"41","author":"Ho","year":"2019","journal-title":"Am. J. Dermatopathol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1097\/prs.0000000000002634","article-title":"Dipeptidyl peptidase-4, wound healing, scarring, and fibrosis.","volume":"138","author":"Hu","year":"2016","journal-title":"Plast. Reconstruct. Surg."},{"key":"B46","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1365-2567.2008.02899.x","article-title":"Differential expression of CD26 on virus-specific CD8(+) T cells during active, latent and resolved infection.","volume":"126","author":"Ibegbu","year":"2009","journal-title":"Immunology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/path.4801","article-title":"PDGFR\u03b1 signalling promotes fibrogenic responses in collagen-producing cells in Duchenne muscular dystrophy.","volume":"240","author":"Ieronimakis","year":"2016","journal-title":"J. Pathol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bbrc.2010.04.092","article-title":"Anomalous expression of Thy1 (CD90) in B-cell lymphoma cells and proliferation inhibition by anti-Thy1 antibody treatment.","volume":"396","author":"Ishiura","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B49","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.3748\/wjg.v19.i15.2298","article-title":"Dipeptidyl peptidase-4: a key player in chronic liver disease.","volume":"19","author":"Itou","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2174\/156652412803833607","article-title":"Fibroblast activation protein in remodeling tissues.","volume":"12","author":"Jacob","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00133","article-title":"Defining skin fibroblastic cell types beyond CD90.","volume":"6","author":"Jiang","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020617","article-title":"Scars or regeneration?-Dermal fibroblasts as drivers of diverse skin wound responses.","volume":"21","author":"Jiang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.diabres.2014.04.028","article-title":"Sitagliptin attenuates methionine\/choline-deficient diet-induced steatohepatitis.","volume":"105","author":"Jung","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B54","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00535-013-0783-4","article-title":"Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats.","volume":"49","author":"Kaji","year":"2014","journal-title":"J. Gastroenterol."},{"key":"B55","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer.","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.2337\/db13-1029","article-title":"4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.","volume":"63","author":"Kanasaki","year":"2014","journal-title":"Diabetes"},{"key":"B57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development.","volume":"21","author":"Kang","year":"2015","journal-title":"Nat. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/hep4.1023","article-title":"Portal fibroblasts marked by the surface antigen Thy1 contribute to fibrosis in mouse models of cholestatic liver injury.","volume":"1","author":"Katsumata","year":"2017","journal-title":"Hepatol. Commun."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/art.34354","article-title":"Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor \u03b2 in the skin of mice with scleroderma-like features and prevents the development of the disease.","volume":"64","author":"Kavian","year":"2012","journal-title":"Arthrit. Rheum."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1002\/art.23696","article-title":"Imatinib mesylate treatment of nephrogenic systemic fibrosis.","volume":"58","author":"Kay","year":"2008","journal-title":"Arthrit. Rheum."},{"key":"B61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drup.2005.03.002","article-title":"Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy.","volume":"8","author":"Kelly","year":"2005","journal-title":"Drug Resist. Updates"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.115246","article-title":"Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1\/2, p38\u03b1, and NF-\u03baB signaling.","volume":"407","author":"Khalil","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1002\/art.30548","article-title":"A one-year, phase I\/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis-associated active interstitial lung disease.","volume":"63","author":"Khanna","year":"2011","journal-title":"Arthrit. Rheum."},{"key":"B64","doi-asserted-by":"publisher","first-page":"186","DOI":"10.4093\/dmj.2018.0271","article-title":"Evogliptin, a Dipeptidyl Peptidase-4 inhibitor, attenuates renal fibrosis caused by unilateral ureteral obstruction in mice.","volume":"44","author":"Kim","year":"2020","journal-title":"Diabetes Metab. J."},{"key":"B65","doi-asserted-by":"crossref","first-page":"L271","DOI":"10.1152\/ajplung.00071.2019","article-title":"Loss of cells expressing fibroblast activation protein has variable effects in models of TGF-\u03b2 and chronic bleomycin-induced fibrosis.","volume":"317","author":"Kimura","year":"2019","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.mam.2017.11.008","article-title":"PDGF in organ fibrosis.","volume":"62","author":"Klinkhammer","year":"2018","journal-title":"Mol. Aspects Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jhep.2015.01.036","article-title":"\u03b2-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis.","volume":"63","author":"Kocabayoglu","year":"2015","journal-title":"J. Hepatol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jid.2018.07.033","article-title":"Lineage identity and location within the dermis determine the function of papillary and reticular fibroblasts in human skin.","volume":"139","author":"Korosec","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/hep.29803","article-title":"Hepatic stellate cell-derived platelet-derived growth factor receptor-alpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2.","volume":"68","author":"Kostallari","year":"2018","journal-title":"Hepatology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1021\/bi5015425","article-title":"Characterization of binding mode of action of a blocking anti-platelet-derived growth factor (PDGF)-B monoclonal antibody, MOR8457, reveals conformational flexibility and avidity needed for PDGF-BB to bind PDGF receptor-\u03b2.","volume":"54","author":"Kuai","year":"2015","journal-title":"Biochemistry"},{"key":"B71","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1053\/j.gastro.2007.10.030","article-title":"Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice.","volume":"134","author":"K\u00fcnzli","year":"2008","journal-title":"Gastroenterology"},{"key":"B72","article-title":"Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression.","volume":"10","author":"Lee","year":"2020","journal-title":"Sci. Rep."},{"key":"B73","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1034\/j.1600-0676.2002.01503.x","article-title":"Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection.","volume":"22","author":"Levy","year":"2002","journal-title":"Liver"},{"key":"B74","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/exd.13800","article-title":"Linagliptin inhibits high glucose-induced transdifferentiation of hypertrophic scar-derived fibroblasts to myofibroblasts via IGF\/Akt\/mTOR signalling pathway.","volume":"28","author":"Li","year":"2019","journal-title":"Exp. Dermatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jhep.2010.11.035","article-title":"Inhibition of PDGF, TGF-\u03b2, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib.","volume":"55","author":"Liu","year":"2011","journal-title":"J. Hepatol."},{"key":"B76","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2337\/db17-0934","article-title":"DPP-4 inhibitors improve diabetic wound healing via direct and indirect promotion of epithelial-mesenchymal transition and reduction of scarring.","volume":"67","author":"Long","year":"2018","journal-title":"Diabetes"},{"key":"B77","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1172\/jci93555","article-title":"Fibroblast heterogeneity: implications for human disease.","volume":"128","author":"Lynch","year":"2018","journal-title":"J. Clin. Invest."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.ajpath.2017.04.017","article-title":"Elevated CD26 expression by skin fibroblasts distinguishes a profibrotic phenotype involved in scar formation compared to gingival fibroblasts.","volume":"187","author":"Mah","year":"2017","journal-title":"Am. J. Pathol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cmet.2017.01.010","article-title":"A PDGFR\u03b1-mediated switch toward CD9(high) adipocyte progenitors controls obesity-induced adipose tissue fibrosis.","volume":"25","author":"Marcelin","year":"2017","journal-title":"Cell Metab."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1096\/fj.04-3253fje","article-title":"EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.","volume":"19","author":"Marleau","year":"2005","journal-title":"FASEB J."},{"key":"B81","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.bbagen.2017.11.012","article-title":"Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice.","volume":"1862","author":"Marques","year":"2018","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1016\/j.ajpath.2016.06.020","article-title":"Altered dermal fibroblasts in systemic sclerosis display podoplanin and CD90.","volume":"186","author":"Nazari","year":"2016","journal-title":"Am. J. Pathol."},{"key":"B84","doi-asserted-by":"crossref","first-page":"L738","DOI":"10.1152\/ajplung.90603.2008","article-title":"Loss of Thy-1 inhibits alveolar development in the newborn mouse lung.","volume":"296","author":"Nicola","year":"2009","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1681\/asn.2008010009","article-title":"CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD.","volume":"20","author":"Okamura","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.devcel.2008.12.003","article-title":"Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis.","volume":"16","author":"Olson","year":"2009","journal-title":"Dev. Cell"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/art.27395","article-title":"Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts.","volume":"62","author":"Ospelt","year":"2010","journal-title":"Arthrit. Rheum."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1097\/01.asn.0000083393.00959.02","article-title":"A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.","volume":"14","author":"Ostendorf","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.addr.2017.09.022","article-title":"PDGF receptors in tumor stroma: biological effects and associations with prognosis and response to treatment.","volume":"121","author":"\u00d6stman","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1042\/CS20180031","article-title":"The role of dipeptidyl peptidase - 4 inhibitors in diabetic kidney disease.","volume":"6","author":"Panchapakesan","year":"2015","journal-title":"Front. Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mam.2017.11.007","article-title":"\/PDGFR pathway as a drug target.","volume":"62","author":"Papadopoulos","year":"2018","journal-title":"Mol. Aspects Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/exd.14228","article-title":"The role of Dipeptidyl Peptidase-4 in cutaneous disease.","volume":"30","author":"Patel","year":"2020","journal-title":"Exp. Dermatol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1016\/j.ajpath.2015.04.016","article-title":"The macrophage phagocytic receptor CD36 promotes fibrogenic pathways on removal of apoptotic cells during chronic kidney injury.","volume":"185","author":"Pennathur","year":"2015","journal-title":"Am. J. Pathol."},{"key":"B94","doi-asserted-by":"crossref","first-page":"2411.e9","DOI":"10.1016\/j.celrep.2019.04.091","article-title":"Blocking antibodies targeting the CD39\/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies.","volume":"27","author":"Perrot","year":"2019","journal-title":"Cell Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jid.2018.01.016","article-title":"Spatial and single-cell transcriptional profiling identifies functionally distinct human dermal fibroblast subpopulations.","volume":"138","author":"Philippeos","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/s1535-6108(03)00089-8","article-title":"PDGF receptors as cancer drug targets.","volume":"3","author":"Pietras","year":"2003","journal-title":"Cancer Cell"},{"key":"B97","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/s0002-9440(10)63694-2","article-title":"Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy.","volume":"163","author":"Pont\u00e9n","year":"2003","journal-title":"Am. J. Pathol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrg.2017.15","article-title":"Scaling by shrinking: empowering single-cell \u2018omics\u2019 with microfluidic devices.","volume":"18","author":"Prakadan","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/j.1365-2133.2012.11186.x","article-title":"Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial.","volume":"167","author":"Prey","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s42255-018-0013-8","article-title":"A metabolic strategy to reverse fibrosis?","volume":"1","author":"Rabinowitz","year":"2019","journal-title":"Nat. Metab."},{"key":"B101","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level.","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1096\/fj.05-5460rev","article-title":"Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis.","volume":"20","author":"Rege","year":"2006","journal-title":"FASEB J."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa2151","article-title":"Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential.","volume":"348","author":"Rinkevich","year":"2015","journal-title":"Science"},{"key":"B104","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1097\/TP.0000000000001679","article-title":"The differential effect of apyrase treatment and hCD39 overexpression on chronic renal fibrosis after ischemia-reperfusion injury.","volume":"101","author":"Roberts","year":"2017","journal-title":"Transplantation"},{"key":"B105","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s11302-016-9528-1","article-title":"CD39 overexpression does not attenuate renal fibrosis in the unilateral ureteric obstructive model of chronic kidney disease.","volume":"12","author":"Roberts","year":"2016","journal-title":"Purinerg. Signal."},{"key":"B106","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11302-019-09664-3","article-title":"Selective deletion of ENTPD1\/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis.","volume":"15","author":"Rothweiler","year":"2019","journal-title":"Purinerg. Signal."},{"key":"B107","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1165\/rcmb.2007-0322oc","article-title":"Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis.","volume":"39","author":"Sanders","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B108","doi-asserted-by":"crossref","first-page":"555.e7","DOI":"10.1016\/j.celrep.2019.12.045","article-title":"Tissue-resident PDGFR\u03b1(+) progenitor cells contribute to fibrosis versus healing in a context- and spatiotemporally dependent manner.","volume":"30","author":"Santini","year":"2020","journal-title":"Cell Rep."},{"key":"B109","doi-asserted-by":"publisher","first-page":"830","DOI":"10.4093\/dmj.2018.0181","article-title":"Gemigliptin attenuates renal fibrosis through down-regulation of the NLRP3 inflammasome.","volume":"43","author":"Seo","year":"2019","journal-title":"Diabetes Metab. J."},{"key":"B110","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3233\/cbm-160590","article-title":"CD90 a potential cancer stem cell marker and a therapeutic target.","volume":"16","author":"Shaikh","year":"2016","journal-title":"Cancer Biomark."},{"key":"B111","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1472-8206.2010.00824.x","article-title":"Nilotinib counteracts thioacetamide-induced hepatic oxidative stress and attenuates liver fibrosis progression.","volume":"25","author":"Shaker","year":"2011","journal-title":"Fund. Clin. Pharmacol."},{"key":"B112","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-020-00903-w","article-title":"Dissecting fibroblast heterogeneity in health and fibrotic disease.","volume":"22","author":"Shaw","year":"2020","journal-title":"Curr. Rheumatol. Rep."},{"key":"B113","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03208-w","article-title":"Direct conversion of injury-site myeloid cells to fibroblast-like cells of granulation tissue.","volume":"9","author":"Sinha","year":"2018","journal-title":"Nat. Commun."},{"key":"B114","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/art.41058","article-title":"Dipeptidylpeptidase 4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in systemic sclerosis.","volume":"72","author":"Soare","year":"2020","journal-title":"Arthrit. Rheumatol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000111507","article-title":"The effect of imatinib (Glivec) on scleroderma and normal dermal fibroblasts: a preclinical study.","volume":"216","author":"Soria","year":"2008","journal-title":"Dermatology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.kint.2015.12.043","article-title":"Antagonism of scavenger receptor CD36 by 5A peptide prevents chronic kidney disease progression in mice independent of blood pressure regulation.","volume":"89","author":"Souza","year":"2016","journal-title":"Kidney Int."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/ard.2010.143974","article-title":"Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial.","volume":"70","author":"Spiera","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"B118","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/prs.0000000000006904","article-title":"Dipeptidyl peptidase-4 inhibitor reduces the risk of developing hypertrophic scars and keloids following median sternotomy in diabetic patients: a nationwide retrospective cohort study using the national database of health insurance claims of Japan.","volume":"146","author":"Suwanai","year":"2020","journal-title":"Plast. Reconstruct. Surg."},{"key":"B119","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-017-0660-4","article-title":"Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition.","volume":"18","author":"Suzuki","year":"2017","journal-title":"Respir. Res."},{"key":"B120","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.matbio.2012.01.006","article-title":"Thrombospondin1 in tissue repair and fibrosis: TGF-\u03b2-dependent and independent mechanisms.","volume":"31","author":"Sweetwyne","year":"2012","journal-title":"Matrix Biol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jid.2017.09.045","article-title":"SFRP2\/DPP4 and FMO1\/LSP1 define major fibroblast populations in human skin.","volume":"138","author":"Tabib","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/mnh.0000000000000291","article-title":"Dipeptidyl peptidase-4 inhibition and renoprotection: the role of antifibrotic effects.","volume":"26","author":"Takagaki","year":"2017","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"B123","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131152","article-title":"Soluble Thy-1 reverses lung fibrosis via its integrin-binding motif.","volume":"4","author":"Tan","year":"2019","journal-title":"JCI insight"},{"key":"B124","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/sj.jid.5701104","article-title":"Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts.","volume":"128","author":"Thielitz","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.yjmcc.2015.08.016","article-title":"Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction.","volume":"87","author":"Tillmanns","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1093\/ibd\/izx008","article-title":"Inhibition of fibroblast activation protein restores a balanced extracellular matrix and reduces fibrosis in crohn\u2019s disease strictures ex vivo.","volume":"24","author":"Truffi","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"B127","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejphar.2016.04.005","article-title":"Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.","volume":"783","author":"Uchii","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"B128","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41592-019-0548-y","article-title":"High-definition spatial transcriptomics for in situ tissue profiling.","volume":"16","author":"Vickovic","year":"2019","journal-title":"Nat. Methods"},{"key":"B129","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1096\/fj.201902001rr","article-title":"Deciphering the functional heterogeneity of skin fibroblasts using single-cell RNA sequencing.","volume":"34","author":"Vorstandlechner","year":"2020","journal-title":"FASEB J."},{"key":"B130","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/01902140701634827","article-title":"Imatinib mesylate inhibits fibrogenesis in asbestos-induced interstitial pneumonia.","volume":"33","author":"Vuorinen","year":"2007","journal-title":"Exp. Lung Res."},{"key":"B131","doi-asserted-by":"crossref","DOI":"10.1186\/1465-9921-10-36","article-title":"Silencing CD36 gene expression results in the inhibition of latent-TGF-beta1 activation and suppression of silica-induced lung fibrosis in the rat.","volume":"10","author":"Wang","year":"2009","journal-title":"Respir. Res."},{"key":"B132","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/hep.20853","article-title":"Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line.","volume":"42","author":"Wang","year":"2005","journal-title":"Hepatology"},{"key":"B133","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1002\/eji.201242434","article-title":"cells participate in CD39-mediated protection from renal injury.","volume":"42","author":"Wang","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-020-2222-z","article-title":"Notch signalling drives synovial fibroblast identity and arthritis pathology.","volume":"582","author":"Wei","year":"2020","journal-title":"Nature"},{"key":"B135","doi-asserted-by":"crossref","first-page":"2515.e3","DOI":"10.1016\/j.jid.2020.04.010","article-title":"CD26 identifies a subpopulation of fibroblasts that produce the majority of collagen during wound healing in human skin.","volume":"140","author":"Worthen","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"B136","first-page":"104","article-title":"Expansion of CD26 positive fibroblast population promotes keloid progression.","volume":"356","author":"Xin","year":"2017","journal-title":"Exp. Cell Res."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41374-018-0080-1","article-title":"Dipeptidyl peptidase IV (DPP-4) inhibition alleviates pulmonary arterial remodeling in experimental pulmonary hypertension.","volume":"98","author":"Xu","year":"2018","journal-title":"Lab. Invest."},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000610","article-title":"Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade.","volume":"8","author":"Yang","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"B139","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrneph.2017.126","article-title":"CD36 in chronic kidney disease: novel insights and therapeutic opportunities.","volume":"13","author":"Yang","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/jcb.21236","article-title":"CD36 is a novel and potential anti-fibrogenic target in albumin-induced renal proximal tubule fibrosis.","volume":"101","author":"Yang","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"B141","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1165\/ajrcmb.23.2.4089","article-title":"A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat.","volume":"23","author":"Yehualaeshet","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"7879","DOI":"10.3892\/mmr.2017.7641","article-title":"PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (Review).","volume":"16","author":"Ying","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"B143","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1053\/j.gastro.2014.08.038","article-title":"Extrahepatic platelet-derived growth factor-\u03b2, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.","volume":"147","author":"Yoshida","year":"2014","journal-title":"Gastroenterology"},{"key":"B144","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.bbrc.2019.02.065","article-title":"Alogliptin alleviates liver fibrosis via suppression of activated hepatic stellate cell.","volume":"511","author":"Zhang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B145","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s42255-018-0008-5","article-title":"Metabolic regulation of dermal fibroblasts contributes to skin extracellular matrix homeostasis and fibrosis.","volume":"1","author":"Zhao","year":"2019","journal-title":"Nat. Metab."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.694605\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T11:16:27Z","timestamp":1672830987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2021.694605\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":145,"alternative-id":["10.3389\/fphys.2021.694605"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2021.694605","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"article-number":"694605"}}